日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Protective effect of pentoxifylline against high-glucose-induced ferroptosis in vascular smooth muscle cells

己酮可可碱对高糖诱导的血管平滑肌细胞铁死亡的保护作用

期刊:Journal of Molecular Endocrinology
影响因子:3.8
doi:10.1530/JME-25-0086
Zhou, Jing; Jiao, Lijing; Jin, Siyao; Ran, Yiwei; Meng, Xian; Bai, Lu; Xi, Yanru; Wang, Jing; Zhao, Zhansheng
细胞生物学
铁死亡
发表日期：2026
文献求助 收藏

Adjuvant Chemotherapy with Traditional Chinese Herbal Granules Versus Placebo in Resected Non-Small Cell Lung Cancer: Updated Survival Analysis of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

中药颗粒辅助化疗与安慰剂治疗切除后非小细胞肺癌的疗效比较：一项多中心、随机、双盲、安慰剂对照试验的最新生存分析

期刊:Integrative Cancer Therapies
影响因子:2.8
doi:10.1177/15347354251409081
Wang, Yichao; Jiao, Lijing; Chen, Zhiwei; Xu, Jianfang; Che, Jiaming; Huang, Hai; Zhang, Lei; Shen, Xiaoyong; Yang, Yi; Zhao, Tiancheng; Zhang, Jie; Zhou, Di; Wang, Qin; Yao, Jialin; Yang, Wenxiao; Sun, Chenbing; Li, Jiaqi; Bi, Ling; Ding, Rongzhen; Goodfellow, Ian; Gong, Yabin; Xu, Ling
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Response to Letter to the Editor Regarding "Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-Small Cell Lung Cancer (NSCLC), a Randomized Controlled Study" in Integrative Cancer Therapies

对《整合癌症疗法》杂志上题为“中医药对非小细胞肺癌（NSCLC）术后康复疗效的随机对照研究”一文的读者来信的回应

期刊:Integrative Cancer Therapies
影响因子:2.8
doi:10.1177/15347354251408741
Gu, Yifeng; Wang, Yichao; Zhou, Huiling; Qi, Ao; Wu, Guanjin; Li, Jiaqi; Yao, Jialin; Yang, Wenxiao; Su, Lingzi; Liu, Yi; Tian, Xueqi; Song, Jiajun; Gong, Yabin; Jiao, Lijing; Xu, Ling; Zhang, Congmeng; Yang, Yong; Qin, Xiong
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
发表日期：2026
文献求助 收藏

Efficacy, safety, and patient-centered outcomes of needle-free injectors versus insulin pens in diabetes management: a comprehensive meta-analysis

无针注射器与胰岛素笔在糖尿病管理中的疗效、安全性和以患者为中心的结果：一项综合荟萃分析

期刊:Drug Delivery
影响因子:8.1
doi:10.1080/10717544.2025.2597906
Wang, Jing; Chen, Xinhao; Ge, Zhili; Xia, Yingran; Tang, Zixiang; Sun, Zehao; Jiao, Lijing; Zhou, Jing; Zhang, Lihui; Zhao, Zhansheng
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Traditional Chinese Medicines as Anticancer Agents for Non-Small Cell Lung Cancer with EGFR Mutations: A Review

传统中药作为EGFR突变型非小细胞肺癌的抗癌药物：综述

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S522445
Wang, Zhiying; Zhong, Zhixian; Yang, Wenxiao; Li, Yun; Zhang, Ke; Gong, Yabin; Jiao, Lijing; Xu, Ling
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Efficacy and safety of needle-free injection in patients with type 2 diabetes mellitus undergoing intensive insulin therapy: a randomized controlled trial based on the flash glucose monitoring system

无针注射治疗2型糖尿病强化胰岛素治疗患者的疗效和安全性：一项基于瞬感血糖监测系统的随机对照试验

期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2025.1652388
Wang, Jing; Liu, Zibo; Jiao, Lijing; Zhou, Jing; Wang, Ting; Li, Caige; Wang, Qian; Yuan, Lingling; Zhang, Fang; Li, Guizhi; Zhu, Qiuxiao; Jin, Siyao; Zhang, Lihui
代谢
糖尿病
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy and safety of Chinese herbal medicine granules plus chemotherapy in patients with EGFR-mutated advanced lung adenocarcinoma post-progression on first-line EGFR-TKI: study protocol for a multicenter, double-blind, randomized controlled trial

中药颗粒联合化疗治疗一线EGFR-TKI治疗进展后EGFR突变晚期肺腺癌患者的疗效和安全性：一项多中心、双盲、随机对照试验的研究方案

期刊:BMC Complementary Medicine and Therapies
影响因子:3.4
doi:10.1186/s12906-025-05037-z
Du, Yizhao; Yao, Jialin; Ye, Xuanting; Wu, Guanjin; Su, Lingzi; Yang, Wenxiao; Jiao, Lijing; Gong, Yabin; Xu, Ling
EGFR
肿瘤
EGF
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study

中医药对非小细胞肺癌（NSCLC）术后康复疗效的随机对照研究

期刊:Integrative Cancer Therapies
影响因子:2.8
doi:10.1177/15347354251314529
Gu, Yifeng; Wang, Yichao; Zhou, Huiling; Qi, Ao; Wu, Guanjin; Li, Jiaqi; Zhang, Congmeng; Yang, Yong; Yao, Jialin; Yang, Wenxiao; Su, Lingzi; Liu, Yi; Tian, Xueqi; Song, Jiajun; Gong, Yabin; Qin, Xiong; Jiao, Lijing; Xu, Ling
肺癌
肿瘤
肿瘤免疫
CLC
细胞生物学
发表日期：2025
文献求助 收藏

GuBenPeiYuan Formula Inhibits Lung Cancer Metastasis by Suppressing Myeloid-Derived Suppressor Cells and Related Immune Cells.

古本培源方通过抑制髓系来源的抑制细胞及相关免疫细胞来抑制肺癌转移

期刊:Integrative Cancer Therapies
影响因子:2.8
doi:10.1177/15347354251324650
Du Yizhao, Zhou Yongming, Jiao Lijing, Yang Wenxiao, Xu Ling, Zhou Hailun, Zhao Jingwen, Li Quanyao, Han Yang, Gong Yabin, Wang Qin
细胞生物学
肺癌
发表日期：2025
文献求助 收藏

Dermatotoxicity of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Advances in Mechanistic Insights and Predictive Biomarker Identification

免疫检查点抑制剂在晚期非小细胞肺癌中的皮肤毒性：机制理解和预测性生物标志物鉴定的最新进展

期刊:Cancer Management and Research
影响因子:2.6
doi:10.2147/CMAR.S528555
Shao, Shiliang; Zheng, Wenjuan; Li, Xuyang; Qi, Ao; Gu, Yifeng; Gong, Yabin; Wang, Qin; Jiao, Lijing; Xu, Ling
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏